#13,672
The expected Monday update on AFM cases from the CDC hasn't posted yet, so the numbers we have remain unchanged from last week (80 cases in 25 states) . Later today the CDC will hold a COCA Call for Health Care Providers on this rare, but serious condition:
Primarily of interest to clinicians and healthcare providers, COCA (Clinician Outreach Communication Activity) calls are designed to ensure that practitioners have up-to-date information for their practices.Call materials haven't been posted yet on the COCA website, so you'll want to visit it prior to the actual presentation. Hopefully we'll see updated AFM numbers later today as well.
Free Continuing Education
Date: Tuesday, November 13, 2018
Time: 2:00pm-3:00pm (Eastern Time)
To access the webinar:
A few minutes before the webinar begins on Tuesday, November 13, 2018,
Please click the link below to join the webinar: https://zoom.us/j/272662215
Or iPhone one-tap :
US: +16699006833,,272662215# or +16468769923,,272662215#
Or Telephone:
Dial(for higher quality, dial a number based on your current location):
US: +1 669 900 6833 or +1 646 876 9923
Webinar ID: 272 662 215
International numbers available: https://zoom.us/u/an2LRvOrY
Overview
The Centers for Disease Control and Prevention (CDC) is actively investigating acute flaccid myelitis, or AFM, a serious condition that causes weakness in the arms or legs. From August 2014 through October 2018, CDC has received information on a total of 396 confirmed cases of AFM across the US; most of the cases have occurred in children. As of October 26, there are 72 confirmed cases of AFM so far in 2018. The patients’ symptoms have been most similar to complications of infection with certain viruses, including poliovirus, non-polio enteroviruses, adenoviruses, and West Nile virus. CDC has not confirmed the cause for the majority of these cases.
During this COCA call, subject matter experts from CDC will highlight the importance of reporting cases to learn more about this condition and the process for reporting. They will also cover specimen collection and testing, and what CDC is doing for its AFM investigation.
